Fig. 7From: Galectin-3 in septic acute kidney injury: a translational studyAcute kidney injury occurrence with and without P-MCP pretreatment in a rat CLP model. Percent AKI with or without P-MCP pretreatment per RIFLE criteria. Within the control group, 16 (89%) rats developed AKI. In each P-MCP group (400Â mg and 1200Â mg), 8 (44%) rats developed AKIBack to article page